Whitepaper: Metabolic response

What happens after we eat?

When we consume mixed-nutrient meals (containing fats, carbohydrates, protein, fiber, and the thousands of other bioactive chemicals in our food), we experience short-term changes in circulating metabolites, which are referred to as postprandial (after a meal) responses (Figure 1).

Postprandial responses can vary hugely between individuals, and this variation is influenced by several complex, interrelated factors that have been studied in detail in the PREDICT program

The most commonly measured features of the postprandial response are changes in blood concentrations of:

  • Glucose (postprandial glycemia)

  • Triglycerides (postprandial lipemia)

  • Insulin (postprandial insulinemia)

Figure 1: Eating a mixed-nutrient meal elicits short-term changes in blood metabolites (triglycerides, glucose, and insulin are shown here) known as a postprandial response. When we map postprandial responses onto a typical eating pattern consisting of multiple meals and snacks, it becomes clear that we spend most of our day in the postprandial state.

Postprandial changes in circulating metabolites are part of a normal, healthy response to a meal. However, repeated, excessive peaks and dips and extended elevated concentrations of these metabolites can overwhelm the body’s natural response mechanisms and trigger a chain of unfavorable metabolic effects (termed excess inflammation after eating) that can lead to a variety of negative short- and long-term health outcomes.

What is 'excess inflammation after eating'?

“Excess inflammation after eating” is how we describe the complex, interrelated chain of unhealthy metabolic effects. These can be triggered in the hours after we eat the “wrong” foods for our biology (depicted in Figure 2) that are associated with unfavorable health outcomes and weight gain over time.

Many different mechanisms are involved in this process, including oxidative stress, lipoprotein remodeling, increased levels of inflammatory markers, and increased hunger and energy (calorie) intake. The gut microbiome may play a role in this process, whereby “good” gut health seems to have a protective effect in minimizing these negative responses.

Ultimately, repeated excess dietary inflammation after eating over months and years contributes to unfavorable, low-grade chronic inflammation, atherosclerosis, and beta cell degeneration, and it may lead to weight gain. These factors are associated with an increased risk of developing obesity, type 2 diabetes (T2D), cardiovascular disease (CVD), and other metabolic diseases. Dietary inflammation after eating is the “black box” that helps us better understand the relationship between diet and how it impacts health outcomes in the long term.

Figure 2: Excess dietary inflammation involves a complex chain of unhealthy metabolic effects that can be triggered after we eat. Over months and years, this can contribute to weight gain and unfavorable health outcomes.

Mechanisms involved in excess inflammation after eating

Research has traditionally focused on single postprandial measures or single parameters of postprandial responses. However, there is a growing awareness that single features of postprandial responses that are typically used (e.g., 0-2h glucose iAUC; 0-6h triglyceride iAUC) do not reflect the multiple postprandial pathophysiologies.

Our PREDICT studies were designed specifically to understand the determinants of excess inflammation after eating related to food at an unprecedented scale and depth(1). This has allowed us to assess the contribution of the many different features of postprandial glycemic, insulinemic, and lipemic responses concerning specific measures of excess inflammation after eating and health outcomes.

Although we discuss each of the core mechanisms individually, it is important to note that the different mechanisms involved in the dietary inflammation process are interlinked. For example, endothelial dysfunction and resulting atherosclerosis are caused, in part, by lipoprotein remodeling, oxidative stress, and inflammation that occurs postprandially (2,3,4).

There is also a complex multidirectional relationship between postprandial responses, insulin resistance, obesity, and T2D, with excess excess inflammation after eating mediating many of the pathways in this relationship. Insulin resistance increases circulating postprandial plasma triglycerides, and conversely increased postprandial lipemia is an inherent feature of diabetic dyslipidemia. It is suggested that in addition to being caused by obesity, insulin resistance and hyperinsulinemia can contribute to its development(5).

1. Acute inflammation and oxidative stress

Research suggests that one adverse effect of dietary lipids and glucose on many chronic conditions, including CVD and T2D, depends on their ability to stimulate a low-intensity and transient inflammatory response(6). Acute inflammation is a normal physiological defense mechanism, yet repeated, sustained postprandial responses may result in chronic low-grade inflammation that is linked to increased risk of cardiometabolic diseases(7,8,9).

Although inflammation can be a consequence of several individual biological factors, it is both chronically (10) and acutely (during the postprandial phase)(11,12) affected by diet. Mechanisms by which postprandial responses trigger an inflammatory response include their effects on oxidative stress (the generation of reactive oxygen species (ROS))(13), hemostatic function (the process of blood clot formation at the site of vessel injury), lipoprotein remodeling(7,14) and endotoxemia(15)(the presence of endotoxins in the blood). 

Several small human studies have investigated the effects of food given as single meals on a handful of inflammatory mediators (typically IL-6 and C-reactive protein) postprandially(12). However, until now, little research has been done to investigate the integrated impact following mixed meals of glycemia and lipemia and their different features on postprandial inflammatory responses, as well as their mechanisms in the context of interrelated and multidirectional biological determinants.

PREDICT 1 was the first study to investigate postprandial inflammation at scale. Through this research, we were able to characterize the impact of both postprandial glycemia and lipemia on inflammatory responses using both traditional (IL-6) and novel (glycoprotein acetyls; GlycA) biomarkers(16).

Our findings show that inflammation (as evidenced by GlycA and IL-6 concentrations) following a meal is highly variable between individuals and that postprandial lipemia was a stronger determinant of inflammation (GlycA), compared with postprandial glycemia. Individuals who experienced a higher postprandial inflammatory response (30% rise in GlycA at 6 h) also had a higher predicted CVD risk, compared to the rest of the cohort.

Given the huge variability in postprandial inflammation observed between individuals and the relationship with postprandial glucose and triglycerides, dietary approaches to target these postprandial elevations may beneficially impact inflammatory-induced chronic disease.

2. Hunger and energy intake

While short-term weight loss is fairly easy to achieve, weight loss interventions often fail in the longterm(17). This is not simply due to a lack of willpower, as multiple biological mechanisms are known to make intentional weight loss difficult and facilitate weight regain(18). Understanding how to modulate appetite in humans is thus a key strategy to consider when developing successful weight loss interventions(19). 

The role of glucose in appetite and weight management was originally proposed by Mayer in his ‘glucostatic hypothesis(20), however until now we have not had a good understanding of how postprandial glycemia might impact appetite beyond appetite signals (e.g. leptin, GLP-1, and other peptides)(21,22), and research has demonstrated that perceived hunger in real-world conditions is poorly correlated with these hormones.

Our studies have collected hundreds of thousands of self-reported appetite readings, combined with detailed free-living food diaries and glucose readings. As a result, for the first time, our research has demonstrated that postprandial glucose dips (also known as blood sugar crashes in the extreme case) in the 2-4 hours after a meal are associated with(23):

  • increased hunger

  • increased calorie consumption (both at the next meal and over the next 24 hours)

  • less time to the next meal

  • reduced alertness in healthy individuals in real-world conditions

The timing of these dips was also associated with indices of insulin sensitivity. These findings suggest that eating certain foods may lead to increased hunger and additional calorie intake and that gaining a better understanding of an individual’s unique responses to foods might be a useful strategy for successful long-term weight loss.

3. Lipoprotein remodeling

Blood lipids, including triglycerides and cholesterol, are transported in lipoproteins of various sizes, shape, and composition, all with different impacts on CVD risk. Triglycerides from the food we eat are transported in the blood in lipoproteins known as chylomicrons, while triglycerides produced by the liver are transported in very-low-density lipoproteins (VLDLs). Chylomicrons and VLDLs are collectively termed triglyceride-rich lipoproteins (TRL)(24). While it might seem alarming to have high levels of fat in the blood, these TRLs are a healthy part of how the body metabolizes dietary fats. 

However, a high and/or extended lipemic response results in triglycerides remaining in the circulation for a longer period, thus promoting an unfavorable remodeling of the circulating lipoproteins. This remodeling is central to the development of what is called the atherogenic lipoprotein phenotype(25,26), namely an increase in remnant lipoproteins (RLP) and small dense triglyceride-enriched high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles, and associated increased CVD risk(7,27). These small changes in the size and composition of lipoprotein subfractions confer different atherogenic potential (the capacity to initiate, increase, or accelerate the process of artery damage) via effects on inflammatory measures, oxidation, and endothelial dysfunction(27,28). 

Our PREDICT results demonstrate that even among healthy individuals there is a postprandial increase in harmful, small, triglyceride-enriched LDL and HDL particles and TRL cholesterol, and a reduction in the protective large cholesterol-enriched HDL particles (unpublished results). However, this response is highly variable between individuals even following a tightly controlled study day involving two standardized test meals. Such that even with a very high fat intake from the standardized meal, some individuals can remove all the triglyceride that enters their blood within a healthy time frame without any apparent metabolic stress, while others experience significant lipemia even at 6 hours, and subsequent remodeling into atherogenic lipoproteins.

These changes and variable responses between individuals were also closely linked with the microbiome. “Good” bugs are associated with a beneficial postprandial lipoprotein profile, whereas “bad” bugs are associated with an unfavorable atherogenic lipoprotein profile.

4. Microbiome remodeling

The gut microbiome can be rapidly modified by diet through the continuous provision of compounds that feed specific gut microbes(29,30). While short-term dietary changes have been shown to rapidly and reproducibly shift the composition of the gut microbiome, these changes appear to be temporary if an individual’s diet returns to “normal”. Habitual dietary intake over months and years is thought to have a greater influence on shaping gut microbiome composition.

An adult’s core gut microbial groups are thought to be resilient to short-term dietary changes. However longer-term shifts in dietary patterns are suggested to have a greater impact on shifting the composition of the gut microbiome towards either a favorable or unfavorable microbiome state, the latter of which we believe to be associated with excess inflammation after eating.

Dysbiosis (broadly defined as an imbalance between “healthy” and “unhealthy” bacteria) is associated with intestinal inflammation, reduced gut barrier integrity, and increased circulating levels of metabolites that may facilitate the development of CVD(32). The gut microbiota has also been suggested to influence insulin resistance and T2D through many pathways that predominantly impact beta-cell function, chronic low-grade inflammation, lipogenesis, and gluconeogenesis(33).

While the relative contribution of the microbiome on excess inflammation after eating is not yet fully understood, the complexity of diet-microbe-metabolite-host interactions is being unraveled and explored in detail through our research. Our research suggests that a complex interplay exists between diet, the gut microbiome, and dietary inflammation after eating, whereby the structure and activity of the gut microbiome are modulated by habitual dietary intake and health. Those microbes also play a key role in a number of the mechanisms involved in excess inflammation after eating and corresponding longer-term health outcomes.

Detailed insights into this synergistic relationship are described in more detail here.

Gut microbial community structure (the composition of a microbial community and the abundance of its members) and diversity (the number of different microbial species) are known to influence postprandial glycemia and lipemia, as well as many of the other mechanisms that form part of the dietary inflammation process. For example, gut microbiome diversity may play a key role in acute inflammation, with findings from our research suggesting that individuals with a higher microbial alpha-diversity and lower visceral fat mass had an attenuated inflammatory response after eating standardized test meals(16).

Research also suggests that lower gut microbiome diversity has been associated with chronic low-grade inflammation(31). Further, our studies have shown that a gut microbiome characterized by a diverse set of “good” microbes is associated with lower excess inflammation after meals, while a gut microbiome dominated by “bad” microbes is associated with higher dietary inflammation after eating.

Combatting excess inflammation after eating through precision nutrition

The relationship between the foods we eat, the gut microbiome, resulting excess inflammation after eating and associated longer-term, unfavorable consequences form part of a vicious cycle. As an individual’s metabolic control gets worse, so does their dietary inflammation after eating. The mechanisms behind this are slow and steady, meaning an occasional “unhealthy” meal is unlikely to cause long-term harm. However, given the significant time, we spend in the postprandial state each day, minimizing unfavorable postprandial responses and resulting excess inflammation after eating is an important strategy to achieve optimal health. Given the modifiable nature of the gut microbiome and its association with either favorable or unfavorable cardiometabolic and obesity-related biomarkers and postprandial responses, cultivating a “healthy” stable gut microbiome through targeted dietary advice is key to optimizing long-term health.

As individuals respond very differently to the same foods, dietary advice focused on minimizing excess inflammation after eating inevitably must be tailored to an individual’s biology for maximum benefit. Through our novel research, we have been able to combine our new understanding of the impact of specific foods on previously poorly studied features of the integrated postprandial responses and the complex interplay between the gut microbiome and diet to develop ZOE scores and recommendations that are personalized to each individual. ZOE scores are designed to promote foods that limit excess inflammation after eating by minimizing the frequency and duration of unfavorable postprandial responses. We believe that by eating in a way that is guided by these personalized recommendations, one might reduce excess inflammation after eating and improve both short- and long-term health outcomes.


Continue reading


  1. Berry SE, Valdes AM, Drew DA et al. Human postprandial responses to food and potential for precision nutrition. Nat Med. 2020;26,964–973. doi:10.1038/s41591-020-0934-0

  2. Barthelmes J, Nägele MP, Ludovici V et al. Endothelial dysfunction in cardiovascular disease and Flammer syndrome-similarities and differences. EPMA J. 2017;8(2):99-109. doi:10.1007/s13167-017-0099-1 

  3. Bonetti PO, Lerman LO & Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168-175. doi:10.1161/01.atv.0000051384.43104.fc 

  4. van Oostrom AJ, Sijmonsma TP, Verseyden C, et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res. 2003;44(3):576-583. doi:10.1194/jlr.M200419-JLR200 

  5. Kahn BB & Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473-481. doi:10.1172/JCI10842 

  6. Margioris AN. Fatty acids and postprandial inflammation. Curr Opin Clin Nutr Metab Care. 2009;12(2):129-137. doi:10.1097/MCO.0b013e3283232a11 

  7. Jackson K, Poppitt S & Minihane A. Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants. Atherosclerosis. 2011;220:22-33. doi:10.1016/j.atherosclerosis.2011.08.012

  8. Peiró C, Romacho T, Azcutia V, et al. Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway. Cardiovasc Diabetol. 2016;15:82. doi:10.1186/s12933-016-0397-2

  9. Node K & Inoue T. Postprandial hyperglycemia as an etiological factor in vascular failure. Cardiovasc Diabetol. 2009;8:23. doi:10.1186/1475-2840-8-23

  10. Lopez-Garcia E, Schulze MB, Fung TT et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2004;80(4):1029-35. doi:10.1093/ajcn/80.4.1029

  11. Meessen ECE, Warmbrunn MV, Nieuwdorp M, Soeters MR. Human Postprandial Nutrient Metabolism and Low-Grade Inflammation: A Narrative Review. Nutrients. 2019;11(12). doi:10.3390/nu11123000

  12. Emerson SR, Kurti SP, Harms CA, Haub MD, Melgarejo T, Logan C, et al. Magnitude and Timing of the Postprandial Inflammatory Response to a High-Fat Meal in Healthy Adults: A Systematic Review. Adv Nutr. 2017;8(2):213-25. doi:10.3945/an.116.014431

  13. Mohanty P, Ghanim H, Hamouda W et al. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr. 2002;75(4):767-72. doi:10.1093/ajcn/75.4.767

  14. Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 1999;84(5):489-97. doi:10.1161/01.res.84.5.489

  15. Laugerette F, Vors C, Peretti N, Michalski MC. Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation. Biochimie. 2011;93(1):39-45. doi:10.1016/j.biochi.2010.04.016

  16. Berry S, Mazidi M, Franks P et al. Impact of Postprandial Lipemia and Glycemia on Inflammatory Factors in over 1000 Individuals in the US and UK: Insights from the PREDICT 1 and InterCardio Studies. Curr Dev Nutr. 2020;4(S2):1518. doi:10.1093/cdn/nzaa068_003

  17. Young-Hyman D. Introduction to special issue: Self-regulation of appetite—it’s complicated. Obesity  2017; 25: S5–7. doi:10.1002/oby.21781

  18. Montesi L, El Ghoch M, Brodosi L, Calugi S, Marchesini G, Dalle Grave R. Long-term weight loss maintenance for obesity: a multidisciplinary approach. Diabetes Metab Syndr Obes 2016; 9: 37–46. doi:10.2147/DMSO.S89836

  19. Melby CL, Paris HL, Foright RM, Peth J. Attenuating the Biologic Drive for Weight Regain Following Weight Loss: Must What Goes Down Always Go Back Up? Nutrients 2017; 9. doi:10.3390/nu9050468

  20. Mayer J. The Glucostatic Theory of Regulation of Food Intake and the Problem of Obesity (a Review). Nutr Rev. 1991 Feb;49(2):46-8. doi:10.1111/j.1753-4887.1991.tb02991.x

  21. Kleinridders A, Ferris HA, Cai W et al. Insulin action in brain regulates systemic metabolism and brain function. Diabetes. 2014;63(7):2232-43. doi:10.2337/db14-0568

  22. Nicolaus M, Brödl J, Linke R et al. Endogenous GLP-1 Regulates Postprandial Glycemia in Humans: Relative Contributions of Insulin, Glucagon, and Gastric Emptying. J Clin Endocrinol Metab. 2011 Jan;96(1):229-36. doi:10.1210/jc.2010-0841

  23. Berry S, Wyatt P, Franks P et al. Effect of Postprandial Glucose Dips on Hunger and Energy Intake in 1102 Subjects in US and UK: The PREDICT 1 Study. Curr Dev Nutr. 2020 Jun;4(S2):1611. doi:10.1093/cdn/nzaa063_009

  24. Packard CJ, Boren J & Taskinen M-R. Causes and Consequences of Hypertriglyceridemia. Front Endocrinol. 2020 May. doi:10.3389/fendo.2020.00252

  25. Sattar N, Petrie JR & Jaap AJ. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis. 1998 Jun;138(2):229-35.10.1016/S0021-9150(98)00037-9

  26. Krauss RM. Atherogenic Lipoprotein Phenotype and Diet-Gene Interactions. The Journal of Nutrition. 2001 Feb;131(2):340S–343S. doi:10.1093/jn/131.2.340S 

  27. Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans. 2003 Oct;31(5):1066-9. doi:10.1042/bst0311066

  28. Daniels TF, Killinger KM, Michal JJ et al. Lipoproteins, cholesterol homeostasis and cardiac health. Int J Biol Sci. 2009;5(5):474-88. doi:10.7150/ijbs.5.474

  29. Leeming ER, Johnson AJ, Spector T. Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration. Nutrients. 2019 Dec;11(12):2862. doi:10.3390/nu11122862

  30. David LA, Maurice CF, Carmody RN et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan 23;505(7484):559-63. doi:10.1038/nature12820

  31. van den Munckhof ICL, Kurilshikov A, Ter Horst R et al. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies. Obes Rev. 2018;19(12):1719-34. doi:10.1111/obr.12750

  32. Battson ML, Lee DM, Weir TL et al. The gut microbiota as a novel regulator of cardiovascular function and disease. J Nutr Biochem. 2018 Jun;56:1-15. doi:10.1016/j.jnutbio.2017.12.010

  33. Tilg H & Moschen AR. Microbiota and diabetes: an evolving relationship. Gut. 2014;63(9):1513-21. doi:10.1136/gutjnl-2014-306928